Rockefeller Capital Management
APTO

Rockefeller Capital Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Rockefeller Capital Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8
Closed -$2K – 4165
2022
Q4 		$2K Hold
8
– – ﹤0.01% 3625
2022
Q3 		$2K Hold
8
– – ﹤0.01% 3651
2022
Q2 		$2K Hold
8
– – ﹤0.01% 3875
2022
Q1 		$5K Sell
8
-40
-83% -$22.1K ﹤0.01% 3374
2021
Q4 		$29K Buy
48
+45
+1,500% +$42.3K ﹤0.01% 2466
2021
Q3 		$3K Hold
3
– – ﹤0.01% 3381
2021
Q2 		$5K Hold
3
– – ﹤0.01% 3056
2021
Q1 		$9K Buy
+3
New +$5.95K ﹤0.01% 2662

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Rockefeller Capital Management's APTO Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Aptose Biosciences, Inc. (APTO) in Q1 2023, closing a stake of 8 shares — an estimated $2K sold.

Rockefeller Capital Management first reported a position in APTO in Q1 2021 and held it in 8 quarters. The position peaked at $29K in Q4 2021. 44 funds tracked by Wall St. Rank hold APTO as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Aptose Biosciences, Inc. position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 8 Aptose Biosciences, Inc. shares in Q1 2023, an estimated $2K.
  • Rockefeller Capital Management first reported a position in Aptose Biosciences, Inc. in Q1 2021 and held it in 8 quarters.
  • Rockefeller Capital Management's Aptose Biosciences, Inc. position peaked at $29K in Q4 2021.
  • 44 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.